Drug intelligence / Profile preview

umbilical cord blood red blood cells

Development stage
Phase 2
Lead developer
Duke University
Modality
Cell Therapies
Administration
Intravenous
01

Overview

Umbilical cord blood red blood cells (UCB-RBCs) are a cellular blood product harvested from the residual blood in the umbilical cord and placenta following childbirth. These cells are distinct from standard adult-derived red blood cells due to their high content of fetal hemoglobin (HbF), which has a significantly higher oxygen affinity than adult hemoglobin (HbA). This biological profile is hypothesized to be better suited for the physiological needs of neonates. UCB-RBCs are primarily developed and investigated as a transfusion source for premature infants, specifically those suffering from anemia of prematurity. By utilizing UCB-RBCs, clinicians aim to reduce the exposure of neonates to multiple adult donors and provide a cell type that more closely mimics the intrauterine environment, potentially improving neurodevelopmental outcomes and reducing transfusion-related complications.

Other names
UCB-RBCscord blood red blood cellsumbilical cord blood-derived red blood cellscord blood erythrocytes

Beyond the preview

Go deeper on umbilical cord blood red blood cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord blood red blood cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call